Community pharmacists’ response to complaints of gastroesophageal reflux: A simulated patient study in the Northern United Arab Emirates

INTRODUCTION: Patients frequently use gastric acid-reducing agents (ARAs) to treat symptoms affecting the gastrointestinal tract. Thus, the risk for drug–drug interactions (DDI) is a serious concern. This potentially makes the community pharmacist (CP) act as a primary intervention by providing the...

Descripción completa

Detalles Bibliográficos
Autores principales: Boura, Fatima, Al-Tabakha, Moawia M., Hassan, Nageeb, Darwich, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821703/
https://www.ncbi.nlm.nih.gov/pubmed/36607970
http://dx.doi.org/10.1371/journal.pone.0279922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821703/
https://www.ncbi.nlm.nih.gov/pubmed/36607970
http://dx.doi.org/10.1371/journal.pone.0279922

Ejemplares similares